Follow
Lluís Fumadó
Lluís Fumadó
Dept. Urology, Hospital del Mar, Barcelona
Verified email at hospitaldelmar.cat
Title
Cited by
Cited by
Year
Prospective, randomized, open‐label, fixed‐dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE‐5 inhibitors
JR Tolrà, JMC Campaña, LF Ciutat, EF Miranda
The Journal of Sexual Medicine 3 (5), 901-909, 2006
902006
Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels
A Font‐Tello, N Juanpere, S De Muga, M Lorenzo, JA Lorente, L Fumado, ...
The Prostate 75 (11), 1216-1226, 2015
842015
MDRD or CKD-EPI for glomerular filtration rate estimation in living kidney donors
C Burballa, M Crespo, D Redondo-Pachón, MJ Pérez-Sáez, M Mir, ...
Nefrología (English Edition) 38 (2), 207-212, 2018
342018
Positive margins after nephron‐sparing surgery for renal cell carcinoma: long‐term follow‐up of patients on active surveillance
MA Lopez‐Costea, L Fumadó, D Lorente, L Riera, EF Miranda
BJU international 106 (5), 645-648, 2010
322010
Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status
R Albero-González, S Hernández-Llodrà, N Juanpere, M Lorenzo, ...
Virchows Archiv 475, 223-231, 2019
242019
Concurrent TMPRSS2‐ERG and SLC45A3‐ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset
S Hernández, A Font‐Tello, N Juanpere, S De Muga, M Lorenzo, ...
The Prostate 76 (9), 854-865, 2016
242016
Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and …
A Sureda, L Fumadó, M Ferrer, O Garin, X Bonet, M Castells, MC Mir, ...
Health and quality of life outcomes 17, 1-9, 2019
222019
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression
S Hernández-Llodrà, N Juanpere, S de Muga, M Lorenzo, J Gil, ...
Oncotarget 8 (43), 74106, 2017
222017
MDRD o CKD-EPI en la estimación del filtrado glomerular del donante renal vivo
C Burballa, M Crespo, D Redondo-Pachón, MJ Pérez-Sáez, M Mir, ...
nefrologia 38 (2), 207-212, 2018
192018
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG‐rearranged prostate cancer
S Hernández‐Llodrà, L Segalés, A Safont, N Juanpere, M Lorenzo, ...
The Prostate 79 (10), 1156-1165, 2019
172019
Preliminary results of the Spanish Association of Urology National Registry in Active Surveillance for prostate cancer
J Rubio-Briones, A Borque, LM Esteban, I Iborra, PA López, JM Gil, ...
Actas Urológicas Españolas (English Edition) 40 (1), 3-10, 2016
152016
Factors associated with renal function compensation after donor nephrectomy.
C Burballa, M Crespo, D Redondo-Pachon, MJ Pérez-Sáez, ...
Nefrologia 38 (5), 528-534, 2018
142018
Sentinel lymph node biopsy in prostate cancer using the SENSEI® drop-in gamma probe
JMA Junquera, A Mestre-Fusco, MR Grootendorst, S Vidal-Sicart, ...
Clinical Nuclear Medicine 47 (1), 86-87, 2022
102022
Programa de monitorización de la vigilancia activa en cáncer de próstata en España de la Sociedad Española de Urología; resultados preliminares
J Rubio-Briones, A Borque, LM Esteban, I Iborra, PA López, JM Gil, ...
Actas Urológicas Españolas 40 (1), 3-10, 2016
102016
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence
S Hernández‐Llodrà, L Segales, N Juanpere, T Marta Lorenzo, M Salido, ...
The Prostate 81 (16), 1267-1277, 2021
92021
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome
L Segalés, N Juanpere, M Lorenzo, R Albero-González, L Fumadó, ...
Virchows Archiv 475, 457-466, 2019
92019
Factors associated with the compensation of renal function after nephrectomy of a kidney donor
C Burballa, M Crespo, D Redondo-Pachón, MJ Pérez-Sáez, ...
Nefrología (English Edition) 38 (5), 528-534, 2018
92018
Twelve core template prostate biopsy is an unreliable tool to select patients eligible for focal therapy
L Fumadó, L Cecchini, N Juanpere, A Ubré, JA Lorente, A Alcaraz
Urologia Internationalis 95 (2), 197-202, 2015
92015
Alargamiento de la vena renal derecha en 120 trasplantes consecutivos. Análisis comparativo
O Arango, JA Lorente, O Bielsa, E Rijo, A Francés, L Fumadó, ...
Actas Urológicas Españolas 37 (3), 135-141, 2013
82013
A drop-in gamma probe for minimally invasive sentinel lymph node dissection in prostate cancer: preclinical evaluation and interim results from a multicenter clinical trial
JMA Junquera, NN Harke, JC Walz, B Hadaschik, J Adshead, ...
Clinical Nuclear Medicine 48 (3), 213-220, 2023
72023
The system can't perform the operation now. Try again later.
Articles 1–20